# Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

> **NCT05057572** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 104 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT05057572
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05057572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05057572, "Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05057572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*